 |
|
Home | AbbVie Price Target Increased to $41.00 by Analysts at BMO Capital Markets (ABBV) |
 |
AbbVie Price Target Increased to $41.00 by Analysts at BMO Capital Markets (ABBV)
|
 |
- January 24, 2013
-
Research analysts at BMO Capital Markets boosted their target price on shares of AbbVie (NASDAQ: ABBV) to $41.00 in a report released on Thursday. The firm currently has an “outperform” rating on the stock. AbbVie traded down 0.57% on Thursday, hitting $37.585. AbbVie has a 1-year low of $33.33 and a 1-year high of $37.84. [...]This article (AbbVie Price Target Increased to $41.00 by Analysts at BMO Capital Markets (ABBV)) was originally developed by and is property of American Banking News. Checkout American Banking News for up-to-date banking news and peer to peer lending news.
- Read more at:http://www.americanbankingnews.com/2013/01/24/abbvie-price-target-increased-to-41-00-by-analysts-at-bmo-capital-markets-abbv/
|
 |
|
 |
|
 |
